Advanced search
Start date
Betweenand
Related content

A METHOD FOR PRODUCING A NANOSTRUCTURED COMPLEX (CFI-1), A PROTEIN-ASSOCIATED NANOSTRUCTURED COMPLEX (MRB-CFI-1) AND USE

OfficeUSPTO
Document type:Patent
Inventor(s): Wagner José Fávaro; Nelson Eduardo Durán Caballero
Applicant:Universidade Estadual de Campinas Unicamp
Year: 2021
Application Number:US20210238046
IPC: A61K 39/39 A61P 31/00 A61P 35/00 C01B 25/02 C01C 1/02 C01F 5/32
Abstract

Disclosed is a method for treating cancer in a subject by administering to the subject a compound selected from NH.sub.4MgPO.sub.4×6H.sub.2O, (NH.sub.4)2MgH.sub.2(PO.sub.4).sub.2×4H.sub.2O, (NH.sub.4)2Mg.sub.3(HPO.sub.4).sub.4×8H.sub.2O and NH.sub.4MgPO.sub.4×H.sub.2O associated or not to hydrolytic enzymes, which are known to have immunomodulatory activities.


FAPESP's process: 17/04383-2 - New therapeutic perspective for non-muscle invasive bladder Cancer: use of the biological response modifier - inorganic phosphate complex 1 (MRB-CFI-1)
Grantee:Melissa Sena da Silva
Principal Investigator:Wagner José Fávaro
Institution: Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB)
Support Opportunities: Scholarships in Brazil - Scientific Initiation